RM

Ross Murdoch

Avecho Biotechnology Limited | Non-Executive Director
Dr Murdoch is an experienced global pharmaceutical, biotechnology and healthcare executive with more than 30 years' experience across listed and private companies in Australia, the United States and Europe. He brings direct experience in neurology and neurodegenerative disease programs, combined with a track record in commercial strategy, operational execution and value realisation across the product lifestyle. Dr Murdoch has held senior leadership roles with AstraZeneca, GlaxoSmithKline and Shire Pharmaceuticals, spanning clinical development, global project leadership, commercial execution and strategic growth initiatives. He also brings United States market experience, having lived and worked in the US across both multinational pharmaceutical and biotechnology companies. His experience includes US clinical development environments, capital markets engagement, strategic transactions and scaling businesses internationally.

Companies and Roles

Company
Title
Tenure
Since
AVE
AVE
Avecho Biotechnology Limited
  • Non-Executive Director
11yrs, 6mthApr 2015
NUZ
NUZ
Neurizon Therapeutics Limited
  • Non-Executive Director
5mthMay 2026

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AVE
AVE
Avecho Biotechnology Limited
10/05/263,333,333N/A3,169,298N/A
NUZ
NUZ
Neurizon Therapeutics Limited
08/05/260N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AVE
AVE
Avecho Biotechnology Limited
27/05/25
Issued
3,169,298$0.005$15,846Issue of options
AVE
AVE
Avecho Biotechnology Limited
29/11/24
Expiry
3,993,644$0.004$15,974Options expired
AVE
AVE
Avecho Biotechnology Limited
10/05/23
Issued
1,666,666$0.006$9,999Rights issue
AVE
AVE
Avecho Biotechnology Limited
10/05/23
Issued
2,499,999$0.004$9,999Rights issue
AVE
AVE
Avecho Biotechnology Limited
31/05/21
Issued
3,993,644$0.019$75,879Issue of options